✦ LIBER ✦

Long-term survival of 106 stage III ovarian cancer patients with minimal residual disease after second-look laparotomy and consolidation radiotherapy

✍ Scribed by Thierry Petit; Michel Velten; Anne d’Hombres; Christian Marchal; Xavier Montbarbon; Françoise Mornex; Philippe Quetin; Jean-Pierre Gérard; Pascale Romestaing; Christian Carrie

Book ID: 113960765
Publisher: Elsevier Science
Year: 2007
Tongue: English
Weight: 192 KB
Volume: 104
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2006.07.034

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-look laparotomy after modified po

Second-look laparotomy after modified posterior exenteration: Patterns of persistence and recurrence in patients with stage III and stage IV ovarian cancer

✍ Nick M Spirtos; Scott M Eisenkop; John B Schlaerth; Samuel C Ballon 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 50 KB

Intraperitoneal Mitoxantrone or Floxurid

Intraperitoneal Mitoxantrone or Floxuridine: Effects on Time-to-Failure and Survival in Patients with Minimal Residual Ovarian Cancer after Second-Look Laparotomy—A Randomized Phase II Study by the Southwest Oncology Group

✍ Franco M. Muggia; P.Y. Liu; David S. Alberts; Darryl L. Wallace; Robert V. O'Too 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 113 KB

Prognostic factors for patients with sta

Prognostic factors for patients with stage IV epithelial ovarian cancer receiving intraperitoneal chemotherapy after second-look assessment : Results of Long-Term Follow-up

✍ Oliver Zivanovic; Richard R. Barakat; Paul J. Sabbatini; Carol L. Brown; Jason A 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

## Abstract ## BACKGROUND. The aim was to determine the long‐term outcome for patients with FIGO stage IV epithelial ovarian carcinoma (EOC) treated with intraperitoneal (IP) chemotherapy after second‐look assessment. ## METHODS. By using data from a retrospective cohort of 433 patients who rece